Our Team

Liquim is staffed by a team of scientists, business professionals,and an advisory board of international specialists. Our leadership team has a history of successfully growing startups and biotech ventures. The team has experience across formulating, biotechnology, product development, and commercialisation.

Grant Pestell

Chairman - Non Executive Director

Spiro Zafiris​

Non-Executive Director

Sheryl Frame

Director -
Chief Executive Officer (CEO)

Velimir Pajic​

Director -
CHIEF SCIENTIFIC OFFICER/FOUNDER​

Zoran Naumoski

Director -
Chief Operations Officer (COO)

Dr Christine Carson

Research Scientist and Scientific Advisor

Dr Jan Sożyński

Research Scientist

Bradley Joblin

Clinical Trials

Dr Željko Perdija

New Medical Applications in Respiratory System

Grant Pestell

Chairman – Non-Executive Director

Currently the managing director of MPH Lawyers, Grant has over 25 years of experience in commercial and corporate law and in commercial litigation. He brings extensive experience advising high net worth clients at both listed and private companies in the information technology, automation and robotics, biotechnology, resources, energy, and construction industries. He also serves as non-executive chair and non-executive director for various listed and private companies.

Grant regularly advises public companies and directors on mergers and acquisitions, corporate governance, and risk management. In the private sector, he works extensively in the innovation space ¬– including biotech, digital, AI, and robotics/automation – advising investors and founders on investment, national and international partnerships, commercialisation and scaling, and IP strategy/protection.

Spiro Zafiris

Non-Executive Director

Spiro’s professional career as an engineer has seen him occupying key management roles in Telstra, primarily in the infrastructure planning area delivering high-capacity, high-availability,and secure data services to key customers in the government, corporate,and mining sector within Australia.

Spiro has managed many technical teams over the years and has been instrumental in implementing change management – including process and system development necessary during structural and disruptive changes within the telecommunications arena.

He has experience and training in contract management and has led senior technical planning teams in Western Australia, South Australia, and Victoria.

Spiro is also consultant to the pharma and medical industry.

Sheryl Frame

Chief Executive Officer (CEO) – Director

Sheryl is a director on numerous boards in addition to being an independent business and commercialisation adviser, strategist, grant consultant, and mentor. Sheryl has a strong background in the healthcare, biomed, and technology sectors.

As well as mentoring on many accelerator programs, Sheryl has worked as a commercialisation adviser to Accelerating Commercialisation – a Federal Government initiative which assists innovative new businesses in their transition from idea to commercial venture. She has founded several technology-based businesses of her own, all of which resulted in a successful exit.

Sheryl also served as a founding director of StartupWA and has since been appointed to the Board of UWA’s Commercialisation Studies Centre. She continues to serve as an Ambassador for both SBE Australia and WITWA.

Sheryl was recognised for her contribution to the ICT sector when she was named Australia’s ICT Professional of the Year for 2019 by the Australian Computer Society.

Velimir Pajic

Director – Chief Scientific Officer/Founder

Vel holds a Bachelor of Medicine Degree from the University of Belgrade, a Bachelor of Science Degree from Curtin University, and a Certificate in Circular Economy and Sustainability Strategies from Judge Business School, Cambridge University.

Liquim’s inception in mid-2020 was due to Velimir‘s vision as a formulator and visionary. Committed to developing and promoting affordable better-health solutions, Vel embarked on a mission to develop plant-derived formulations to aid people and planet.

Vel’s aspiration was to create products that could serve as complementary medicine and be readily accessible without a prescription.

With a formidable background in research and the development of over-the-counter medicines, Vel has successfully taken innovations to the Australian and global markets. As a founder of Australian biotech company, Better Nature, Vel was responsible for developing their pain relief product range. Other formulations Vel has developed vary from “herlip,” rapid relief plant-based product for cold sores to ad-hoc formulations in the food and OTC space.

Zoran Naumoski

Director – Chief Operations Officer (COO)

Zoran has over 20 years of experience working in the capacity of services contract manager onshore and offshore, with key responsibilities in contract implementation, QA/QC of contractual deliveries.

Zoran was engaged as Chief Supply Chain Officer for Better Nature, with full responsibilityfor logistics, including contract manufacturing, procurement and shipping nationally and internationally. Zoran has a wealth of experience in developing packaging compliant with TGA and FDA (USA) registrationsproducts and Hong Kong cosmeceuticals.

Dr Christine Carson

Research Scientist and Scientific Advisor

Christine is a natural-product researcher who works in partnership with industry. She has extensive expertise in assessing the antimicrobial activity of compounds, in vitro and vivo , along with deep knowledge of the inflammatory and analgesic properties of natural products.

Dr Jan Sożyński

Research Scientist

Jan adds significant value to Liquim through his extensive expertise in organic chemistry, encompassing both synthesis and analysis. His proficiency in maintaining high-standard laboratory operations and equipment is a testament to his dedication and competence.

Jan holds a Doctor of Philosophy in Chemistry, reflecting his commitment to advancing the field and his depth of knowledge in his chosen discipline. His capabilities in research and development contribute to Liquim’s current success and position in the industry.

Bradley Joblin

Clinical Trials

Bradley is an expert in developing strategies to bring therapeutic discoveries to market, providing insight into modern practices for evidence generation, and preclinical and clinical development planning. He is passionate about science, technology, and novel approaches to deliver innovative therapies to patients. Bradley’s experience covers translational medicine, early phase study design, global implementation of phase study design, global implementation of phase III studies, and clinical development strategy.

Dr Željko Perdija

New Medical Applications in Respiratory System

Željko has completed subspecialisations in the fields of pulmonology and gastroenterology, as well as a professional postgraduate study in the field of ultrasound in gastroenterology and hepatology, which he completed at the Medical Faculty of the University of Zagreb. Željko is a new member of the Liquim team and will be contributing to advancing current IP into new medical applications. Dr. Perdija is a director of internal medicine at the Center for Internal and Interventional Medicine (CiiMplus) in Maribor, Slovenia.

Disclaimer

This website is designed to serve individuals interested in gathering information regarding Liquim Limited for investment or business purposes. The website includes details about products that may have varying availability or trademarks in different countries or for different purposes. If you are looking for information about Liquim products, we recommend you visit the dedicated product website in your country of residence. It's important to note that nothing presented on this website should be construed as solicitation, promotional material, or advertising for any product, including those in development. Furthermore, the information provided on this website is not intended to offer medical advice, and it should not be used as a substitute for guidance from a qualified healthcare professional or physician.